1. Home
  2. WULF vs GKOS Comparison

WULF vs GKOS Comparison

Compare WULF & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TeraWulf Inc.

WULF

TeraWulf Inc.

N/A

Current Price

$13.87

Market Cap

6.8B

Sector

Technology

ML Signal

N/A

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$105.68

Market Cap

6.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WULF
GKOS
Founded
1952
1998
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
6.9B
IPO Year
1999
2015

Fundamental Metrics

Financial Performance
Metric
WULF
GKOS
Price
$13.87
$105.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
14
Target Price
$17.96
$133.07
AVG Volume (30 Days)
30.3M
666.0K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$168,455,000.00
$507,442,000.00
Revenue This Year
$139.73
$23.39
Revenue Next Year
$178.09
$27.46
P/E Ratio
N/A
N/A
Revenue Growth
20.28
32.33
52 Week Low
$2.06
$73.16
52 Week High
$18.51
$130.23

Technical Indicators

Market Signals
Indicator
WULF
GKOS
Relative Strength Index (RSI) 42.68 36.71
Support Level $11.30 $104.72
Resistance Level $16.76 $106.52
Average True Range (ATR) 1.30 4.82
MACD -0.37 -1.34
Stochastic Oscillator 13.34 21.68

Price Performance

Historical Comparison
WULF
GKOS

About WULF TeraWulf Inc.

TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: